Literature DB >> 21396346

Quantitation of a recombinant monoclonal antibody in monkey serum by liquid chromatography-mass spectrometry.

Hongcheng Liu1, Anton V Manuilov, Chris Chumsae, Michelle L Babineau, Edit Tarcsa.   

Abstract

A method including protein A purification, limited Lys-C digestion, and mass spectrometry analysis was used in the study to quantify a recombinant monoclonal antibody in cynomolgus monkey serum. The same antibody that was isotopically labeled was used as an internal standard. Interferences from serum proteins were first significantly reduced by protein A purification and then by limited Lys-C digestion of protein A bound IgG, including both monkey and the recombinant IgG. Fab fragment of the recombinant human IgG was analyzed directly by LC-MS, while monkey IgG and the Fc fragment of the recombinant human IgG remained bound to protein A resin. Quantitation was achieved by measuring the peak intensity of the Fab from the recombinant human IgG and comparing it to that of the Fab from the stable isotope-labeled internal standard. The results were in good agreement with the values from ELISA. LC-MS can therefore be used as a complementary approach to ELISA to quantify recombinant monoclonal antibodies in serum for pharmacokinetics studies and it can also be used where specific reagents such as antigens are not readily available for ELISA.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396346     DOI: 10.1016/j.ab.2011.03.004

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Simultaneous analysis of multiple monoclonal antibody biotherapeutics by LC-MS/MS method in rat plasma following cassette-dosing.

Authors:  Hongyan Li; Robert Ortiz; Linh T B Tran; Hossein Salimi-Moosavi; Jennifer Malella; Christopher A James; Jean W Lee
Journal:  AAPS J       Date:  2012-12-12       Impact factor: 4.009

2.  Critical role of bioanalytical strategies in investigation of clinical PK observations, a Phase I case study.

Authors:  Kun Peng; Keyang Xu; Luna Liu; Robert Hendricks; Reginald Delarosa; Rich Erickson; Nageshwar Budha; Maya Leabman; An Song; Surinder Kaur; Saloumeh K Fischer
Journal:  MAbs       Date:  2014       Impact factor: 5.857

3.  A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines.

Authors:  Brian J Geist; Darryl Davis; Thomas McIntosh; Tong-Yuan Yang; Kenneth Goldberg; Chao Han; Charles Pendley; Hugh M Davis
Journal:  MAbs       Date:  2012-11-26       Impact factor: 5.857

4.  Qualification and Application of a Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometric Method for the Determination of Adalimumab in Rat Plasma.

Authors:  Yuri Park; Nahye Kim; Jangmi Choi; Min-Ho Park; Byeong Ill Lee; Seok-Ho Shin; Jin-Ju Byeon; Young G Shin
Journal:  Pharmaceutics       Date:  2018-05-24       Impact factor: 6.321

5.  Assessments of the In Vitro and In Vivo Linker Stability and Catabolic Fate for the Ortho Hydroxy-Protected Aryl Sulfate Linker by Immuno-Affinity Capture Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometric Assay.

Authors:  Byeong Ill Lee; Seo-Jin Park; Yuri Park; Seok-Ho Shin; Jang-Mi Choi; Min-Jae Park; Jeong-Hyeon Lim; Sun Young Kim; Hyangsook Lee; Young G Shin
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.